Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adel S El-Azab

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
RSC Advances|April 24, 2026
Discovery of thieno[2,3-<i>d</i>]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and <i>in vivo</i> validation in a breast cancer modelHamed W El-Shafey, Abdelrahman Hamdi, Mohamed R Elnagar, et al.
Bioorganic Chemistry|September 8, 2019
Synthesis and comparative carbonic anhydrase inhibition of new Schiff's bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffoldsAdel S El-Azab, Alaa A-M Abdel-Aziz, Silvia Bua, et al.
Profiles of Drug Substances, Excipients, and Related Methodology|February 29, 2024
Avanafil: A comprehensive drug profileAbdulrahman A Al-Majed, Amer AlKhairallah, Mohamed W Attwa, et al.
Bioorganic Chemistry|March 18, 2019
Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Sivia Bua, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 4, 2020
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Hany E A Ahmed, et al.
Bioorganic Chemistry|March 29, 2019
Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivativesAlaa A-M Abdel-Aziz, Adel S El-Azab, Silvia Bua, et al.
Profiles of Drug Substances, Excipients, and Related Methodology|February 29, 2024
Ponatinib: A comprehensive drug profileMohamed W Attwa, Hamad M Alkahtani, Adel S El-Azab, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 11, 2015
Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studiesAmer M Alanazi, Alaa A-M Abdel-Aziz, Taghreed Z Shawer, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 20, 2020
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Silvia Bua, et al.
Molecules (Basel, Switzerland)|November 26, 2022
Carbonic Anhydrase Inhibition Activities of Schiff's Bases Based on Quinazoline-Linked BenzenesulfonamideAdel S El-Azab, Alaa A-M Abdel-Aziz, Hazem A Ghabbour, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
RSC Advances|April 24, 2026
Discovery of thieno[2,3-<i>d</i>]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and <i>in vivo</i> validation in a breast cancer modelHamed W El-Shafey, Abdelrahman Hamdi, Mohamed R Elnagar, et al.
Bioorganic Chemistry|September 8, 2019
Synthesis and comparative carbonic anhydrase inhibition of new Schiff's bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffoldsAdel S El-Azab, Alaa A-M Abdel-Aziz, Silvia Bua, et al.
Profiles of Drug Substances, Excipients, and Related Methodology|February 29, 2024
Avanafil: A comprehensive drug profileAbdulrahman A Al-Majed, Amer AlKhairallah, Mohamed W Attwa, et al.
Bioorganic Chemistry|March 18, 2019
Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Sivia Bua, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 4, 2020
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Hany E A Ahmed, et al.
Bioorganic Chemistry|March 29, 2019
Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivativesAlaa A-M Abdel-Aziz, Adel S El-Azab, Silvia Bua, et al.
Profiles of Drug Substances, Excipients, and Related Methodology|February 29, 2024
Ponatinib: A comprehensive drug profileMohamed W Attwa, Hamad M Alkahtani, Adel S El-Azab, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 11, 2015
Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studiesAmer M Alanazi, Alaa A-M Abdel-Aziz, Taghreed Z Shawer, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 20, 2020
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Silvia Bua, et al.
Molecules (Basel, Switzerland)|November 26, 2022
Carbonic Anhydrase Inhibition Activities of Schiff's Bases Based on Quinazoline-Linked BenzenesulfonamideAdel S El-Azab, Alaa A-M Abdel-Aziz, Hazem A Ghabbour, et al.
Pageof 11